Protein & Structure - Sygnature Discovery Email Format

Biotechnology ResearchEngland, United Kingdom11-50 Employees

Protein & Structure – Sygnature Discovery operates in biotechnology research, bridging protein science with structure-based drug discovery. It supports drug discovery programs across the gene-to-structure continuum and delivers proteins in formats suitable for assay development, high-throughput screening, biophysics, or structure-based design. The firm tailors its services to the client’s stage in the process and has a track record of timely, reliable protein expression and structural deliverables.

Based in Macclesfield, North West England, the company is a mid-sized biotechnology research organization. In February 2026, Sygnature Discovery announced a collaboration with STORM Therapeutics to advance a DHX9 inhibitor program toward a preclinical development candidate.

Sign up for free to view info

Company overview Employee directory